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Neurofibromatosis type 1 patients develop peripheral
nerve tumors (neurofibromas) composed mainly of
Schwann cells and fibroblasts, in an abundant collagen
matrix produced by fibroblasts. Trauma has been
proposed to trigger neurofibroma formation. To test
if loss of the neurofibromatosis type 1 gene (Nf1)
compromises fibroblast function in vivo following
trauma, skin wounding was performed in Nf1 knockout
mice. The pattern and amount of collagen-rich granu-
lation bed tissue, manufactured by fibroblasts, was
grossly abnormal in 60% of Nf1F/– wounds. Nf1
mutant fibroblasts showed cell autonomous abnormal-
ities in collagen deposition in vitro that were not
mimicked by Ras activation in fibroblasts, even though
Neurofibromatosis type 1 (NF1) is one of the mostcommon inherited autosomal dominant humandiseases, affecting 1 in 3500 individuals (Husonet al, 1989; Riccardi, 1992). Patients with NF1develop benign peripheral nerve sheath tumors
called neurofibromas. These tumors contain two major cell types:
fibroblasts and Schwann cells. Mutations in both Nf1 alleles are
detectable in neurofibromas, suggesting that one of these cell types
has sustained mutations in both copies of the Nf1 tumor suppressor
gene (Colman et al, 1995; Sawada et al, 1996). Whether Nf1
mutations in Schwann cells alone, fibroblasts alone, or in both cell
types contribute to neurofibroma formation is unclear (reviewed
in Rosenbaum et al, 1997).
Neurofibroma fibroblasts and Schwann cells are embedded in
an extensive connective tissue matrix containing a large amount of
collagens, proteoglycans, fibronectin, and laminin (Uitto et al, 1986;
Konomi et al, 1989). Up to 70% of the tumor dry weight of a
neurofibroma is collagen (Peltonen et al, 1986; Uitto et al, 1986).
Type I collagen is the major species, with collagens types III and
V present in lesser amounts (Uitto et al, 1986; Konomi et al, 1989).
Neurofibroma fibroblasts, which account for 20%–60% of the cells
within the tumors, synthesize collagen I and III (Peltonen et al,
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some Nf1 effects are mediated through Ras. Nf1F/–
skin wound fibroblasts also proliferated past the normal
wound maturation phase; this in vivo effect was potenti-
ated by muscle injury. In vitro, Nf1F/– fibroblasts
showed higher proliferation in 10% serum than Nf1F/
F fibroblasts. Macrophage-conditioned media or epi-
dermal growth factor potentiated Nf1F/– fibroblast
proliferation in vitro, demonstrating abnormal response
of mutant fibroblasts to wound cytokines. Thus Nf1 is
a key regulator of fibroblast responses to injury, and
Nf1 mutation in mouse fibroblasts causes abnormalities
characteristic of human neurofibromas. Key words:
epidermal growth factor/macrophage/neurofibromin/Ras. J
Invest Dermatol 112:835–842, 1999
1988; Jaakkola et al, 1989; Sollberg et al, 1991). In comparison with
normal skin fibroblasts, early passage fibroblasts from neurofibromas
synthesize and secrete higher amounts of collagen (Peltonen et al,
1981, 1986; Uitto et al, 1986; Sasaki et al, 1992). These studies
imply that fibroblasts might contribute to the pathogenesis of
neurofibromas. It is not known, however, if fibroblasts in neuro-
fibromas behave abnormally in response to the tumor environment
or as a result of NF1 mutation.
The NF1 gene product, neurofibromin, has a Ras-GTPase
activating protein (Ras-GAP) related domain (reviewed in Kim
and Tamanoi, 1998). Neurofibromin functions as a Ras-GAP in
some cell types (Basu et al, 1992; DeClue et al, 1992; Kim et al,
1995; Largaespada et al, 1996). Ras-GTP levels are high in
neurofibromas (Guha et al, 1996) suggesting that Ras is aberrantly
regulated in one or more neurofibroma cell types. Neurofibromin
may also have non-Ras functions (Johnson et al, 1993; Griesser
et al, 1997; Guo et al, 1997; Kim et al, 1997). Neurofibromin
accounts for about 15% of the Ras-GAP activity in fibroblasts
(Kobayashi et al, 1993), but the relative contributions of Ras and
non-Ras functions of neurofibromin in fibroblasts are not known.
To assess fibroblast abnormalities resulting from Nf1 mutation,
we have used mice with a targeted mutation in the Nf1 gene
(Brannan et al, 1994; Jacks et al, 1994). We previously showed that
embryonic fibroblasts cultured from the Nf1-null mutant embryos
hyperproliferate and fail to form perineurium in vitro (Rosenbaum
et al, 1995), suggesting that loss of neurofibromin is sufficient to
lead to fibroblast abnormalities. Neurons (Vogel et al, 1995),
Schwann cells (Kim et al, 1995, 1997, and myeloid cells (Largaespada
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et al, 1996) derived from these mutant mice have been characterized
and also exhibit abnormalities.
Because Nf1-null (Nf1–/–) mice die by embryonic day 14.5 and
adult heterozygous (Nf11/–) mice do not spontaneously develop
neurofibromas or skin abnormalities, we challenged Nf11/– animals
using a well-characterized skin wound-healing model to assess
fibroblast function in vivo (Greenhalgh et al, 1990; Brown et al,
1994). In particular, the wound-healing model facilitates the deter-
mination of the extent and control of fibroblast proliferation and
collagen deposition (Mast, 1992), two key features of neurofibromas,
in an environment-dependent manner. Several striking similarities
exist between the wound healing and tumor environments including
the presence of similar growth factors and cytokines, proliferation
and migration of multiple cell types, angiogenesis, and matrix
remodeling (Dvorak, 1986; Martin, 1997). Furthermore, one
hypothesis based on patient observations suggests that neurofibroma
formation may be triggered after injury (Riccardi, 1992). Indeed,
neurofibromin expression is upregulated in fibroblasts during skin
wound healing (Yla¨-Outinen et al, 1998). We show here that
Nf11/– mouse skin wounds have abnormal granulation tissue
(containing mostly collagen) in dermal scars after excisional
wounding. We also show that Nf1–/– fibroblast cultures have an
increase in deposited collagen. Furthermore, fibroblasts in the
granulation bed of Nf11/– wounds proliferate beyond the normal
time frame. In culture, Nf11/– fibroblasts also have increased
proliferation that is further potentiated by macrophage-conditioned
media or epidermal growth factor (EGF). These data are consistent
with Nf1 mutations in fibroblasts contributing to the enhanced
collagen deposition and proliferation which are characteristic of
neurofibromas, and indicate that neurofibromin plays a novel role
in wound healing.
MATERIALS AND METHODS
Reagents MEKK inhibitor (29-amino-39methoxyflavone) was purchased
from Calbiochem (La Jolla, CA). Alpha-[32P]-dATP was purchased from
Amersham Life Sciences (Arlington Heights, IL) and 2,3,4,5-[3H]-Proline
was obtained from DuPont-NEN (Boston, MA). Farnesyltransferase inhib-
itor L744832 was a gift of N. Kohl, Merck Sharp Dohme Research
Laboratory. All purified growth factors were purchased from R&D Systems
(Minneapolis, MN).
Cell culture Fibroblasts were isolated from embryonic day 12.5 mice as
previously described (Rosenbaum et al, 1995). Cells were maintained in
DMEM (Gibco Laboratories, Gaithersburg, MD) plus 10% (vol/vol) fetal
bovine serum (Harlan, Indianapolis, IN) and 1% penicillin–streptomycin
(Gibco/BRL) in 7.4% CO2 at 35°C. Cells from passages 1–5 were used
for all in vitro experiments. For collagen deposition assays, fibroblasts were
seeded in 35 mm dishes (Fisher, Pittsburgh, PA) at a density of 2 3 105 cells
per well (cells reached coNfluence in 2 d). Sixteen to 20 hours after
plating, the media was supplemented with 40 g per ml ascorbate (Sigma,
St. Louis, MO) and was changed every third day.
Transfected cells V-H-ras expressing Nf11/1 cells were obtained by
iNfecting cells with retrovirus containing V1259T v-ras (DeClue et al,
1992). Cells were selected in 300 µg per ml of Gentamycin antibiotic
(Gibco). V-H-ras expressing Nf11/1 fibroblasts hyperproliferated and
exhibited transformed morphology. Clones were pooled and used for
experiments.
Skin wounding and analysis Male C57/BL6 Nf11/1 (n 5 26) and
heterozygous Nf11/– littermates (n 5 40) were used for full thickness
skin wounding experiments as previously described (Greenhalgh et al,
1990; Brown et al, 1994). Mice were 8–10 wk old at the time of wounding.
All procedures were approved by the Institution of Animal Care and Use
Committee at University of Cincinnati. Animals had been backcrossed
seven to nine generations onto the C57/BL6 background. Wounding
was performed under aseptic conditions. Mice were anesthetized by
methoxyflurane inhalation (Mallinckrodt Veterinary, Mundelein, IL). Back
skin was shaved and prepped with povidone-iodine solution and wiped with
70% isopropyl alcohol. A full-thickness wound measuring approximately
1.5 cm 3 1.5 cm was created by excising the skin on the mid-back,
including the panniculus carnosus. Some Nf11/1 and Nf11/– mice were
given the full-thickness skin wound together with a single nick in the
underlying spinalis muscle with a scalpel blade (2–3 mm in depth and 1 cm
in length). Tincture of benzoin (Cumberland-Swan, Smyrna, TN) was
applied to the perimeter of the wound and allowed to dry. The wound
was covered with a transparent, nonabsorbent dressing (OpSite; Smith and
Nephew Medical Ltd, Hull, U.K.). Animals were killed by sodium
pentobarbitol overdose at 1, 2, 4, 6, 8, 10, or 12 wk postwounding. The
entire wound, including a 5 mm margin of unwounded skin was then
excised down to the fascia. The wounds were either placed in buffered
4% paraformaldehyde, cryoprotected in 20% sucrose/0.1 M phosphate-
buffered solution, and frozen for cryostat sectioning, or fixed in formalin,
processed for paraffin embedding, sectioned, and processed for routine
staining or as designated below.
At least four random sections spanning the length of 4 wk old skin
wounds with and without muscle injury were stained with biotinylated
anti-proliferating cellular nuclear antigen (PCNA) (ZYMED, San Francisco,
CA) and counterstained with hematoxylin according the manufacturer’s
directions. Five hundred total nuclei were analyzed per section in multiple
sections of each wound and the percentage of PCNA labeled nuclei was
calculated. Student’s t-test analysis was performed to determine the statistical
significance between the different groups.
The extent of wound closure of multiple groups over time were
compared using one-between, one-within repeated measures ANOVA.
Statistical procedures were performed using SAS software (version 6.04,
SAS Institute, Cary, NC) as described (Greenhalgh et al, 1990; Brown
et al, 1994).
Cell density measurements were obtained by counting the number of
hematoxylin-stained nuclei in skin wounds (with muscle injury) in at least
five different fields per section, in multiple sections per wound. Cell density
was calculated using NIH Image (written by Wayne Rasband at the U.S.
National Institute of Health and available from the Internet by anonymous
ftp from zippy.nimh.nih.gov). The nonparametric Wilcoxon rank sum test
was used to determine statistical significance.
Fibroblast Proliferation assay and macrophage-conditioned
media Proliferation of cultured embryonic fibroblasts was analyzed as
previously described, in DMEM 1 10% FBS (Rosenbaum et al, 1995).
Methods for harvesting and culturing mouse peritoneal macrophages were
those of Griffin and Silverstein (1974) except that DMEM media 1 10%
FBS 1 100 U per ml penicillin 1 100 g per ml streptomycin was
conditioned by 0.5 3 106 macrophages per ml for 48 h and stored at –
70°C. Eight day fibroblast growth assays were performed using 50%
macrophage-conditioned media; 200 µl macrophage-conditioned media
and 200 µl of DMEM 1 10% FBS were added to triplicate cultures in 24
well plates at days 1 and 4. EGF (R&D Systems) 1 FBS and EGF 1 250 nM
AG1478 (Calbiochem) (Daub et al, 1996) 1 FBS were added similarly.
The day of plating was designated day 0.
Measurement of collagen matrix deposition Quantitation of accu-
mulated collagen matrix deposited by fibroblasts over a 14 d period was
done by performing colorimetric assay of total hydroxyproline content as
described (Berg, 1982), and then normalized to total amount of protein
soluble in 0.1% sodium dodecyl sulfate, 1% triton X-100 (Eldridge
et al, 1987).
RESULTS
Skin wounds in Nf1F/– mice demonstrate abnormal wound
repair and an increase in granulation tissue To test the
hypothesis that loss of neurofibromin function causes fibroblast
dysfunction, we challenged Nf11/– fibroblasts in vivo using a full-
thickness skin wound-healing model. Before wounding, Nf11/1
and Nf11/– skin appeared normal by gross examination and in
histology sections (data not shown). The overall rate of re-
epithelialization over 0–18 d in Nf11/1 (n 5 12) and Nf11/–
(n 5 15) murine wounds did not differ significantly (data not
shown). Histologic analysis of wounded skin was used to determine
key spatial and temporal features of the healing process. Random
sections spanning the wound were stained with either hematoxylin
and eosin or Gomori’s trichrome. Sections were examined for gross
changes in the degree of cellular infiltration, granulation tissue
formation, vascularity, re-epithelialization, and collagen deposition.
We did not find any obvious differences in the degree of inflam-
matory cell infiltration, angiogenesis, or re-epithelialization (with
the exceptions noted below); subtle changes cannot be excluded.
In contrast to Nf11/1 wounds (Fig 1A), many Nf11/– wounds,
however, had a profoundly abnormal pattern of granulation tissue
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distribution in which the granulation bed of the regenerated dermis
invaded the underlying muscle fibers (Fig 1B black arrowheads).
This unusual phenotype was not observed in any of the Nf11/1
wounds examined in this study, nor in any of the more than 100
mice analyzed previously after excisional wounding (Greenhalgh
et al, 1990; Brown et al, 1994).
To assess the frequency and timing of the abnormality, wounds
were examined between 1 and 12 wk postwounding. Wounds
were scored as abnormal if the pattern of fibrotic tissue distribution
was unorganized and penetrated underlying muscle fibers in at least
one section per wound. Sectioning of half the wound beds of a
total of 27 Nf11/– mice from various time points showed the
granulation bed penetrating the underlying muscle in 50% of the
wounds. This phenotype was evident as early as 2 wk postwounding.
To determine if abnormal histology was present in all wounds,
complete 4 wk old wound beds of 13 additional Nf11/– mice
were serially sectioned and examined. Sixty per cent of wound
beds were scored as histologically abnormal. We conclude that a
majority of Nf11/– wounds have an abnormal pattern of granula-
tion tissue. To examine the possibility that accidental wounding of
muscle contributes to the wound-related phenotype observed in
Nf11/– mice, we performed full-thickness skin wounding and
nicked the underlying muscle of Nf11/1 and Nf11/– mice.
Wounds were harvested at 4 wk after wounding and serially
sectioned. All of the Nf11/1 (three of three) mice showed
complete, normal skin regeneration (Fig 1C); however, three of
five of Nf11/– wound beds had an abnormal pattern of matrix in
the granulation bed (Fig 1D). The collagen matrix in the Nf11/–
mouse wound beds penetrated into the muscle layer and encircled
muscle fascicles (Fig 1D). We conclude that muscle nicking is not
sufficient to elicit in (Nf11/1) mice or exacerbate in the (Nf11/–
mice) the granulation bed phenotype of Nf11/– wounds.
Using higher magnification, the dermal scar consists of elongated
nuclei in the collagen-rich matrix of both Nf11/1 (Fig 1E) and
Nf11/– (Fig 1F) scars. Most of these cells are believed to be
fibroblasts, which produce the surrounding matrix. Collagenous
matrix penetrating the muscles in Nf11/– wounds tended to be
less compacted (Fig 1G) than the underlying regenerated dermis
of Nf11/1 scars, but also contained elongated fibroblast nuclei.
In addition to the excessive granulation tissue in the Nf11/–
wounded skin, rarer phenotypes were detected. At 4 wk post-
wounding, failure to re-epithelialize was observed in three of 40
Nf11/– mice versus none of 26 Nf11/1 mice. In one Nf11/–
mouse, the collagen matrix erupted above the skin layer (Fig 2A).
In two Nf11/– mice, the wound had clear signs of delayed wound
contracture and delayed healing (Fig 2B, C), excessive angiogenesis
(Fig 2C), as well as failure to re-epithelialize completely (Fig 2C).
In order to quantitate the amount of granulation tissue, the area
and the depth of the regenerated dermis were analyzed in paraffin
sections from 12 Nf11/– and six Nf11/1 mice 4 wk after
wounding (Fig 3). The area of the regenerated dermis was measured
using Metamorph software in four to seven different sections at
intervals spanning each wound, by measuring from the neoepithe-
lium to the muscle layer in height, and to the normal skin interface
on either side of the wound in width. The depth of each wound
was measured by calculating the distance from the neoepithelium
to the muscle layer in the same sections. In comparison with
Nf11/1 wounds, most but not all Nf11/– wounds showed an
increase in the area and depth of the regenerated dermal scar even
though sections without overt granulation bed distortion were
included in the analysis (Fig 3). The depth and the area of the
dermal scar in the Nf11/– group was significantly larger than the
Nf11/1 wounds (p , 0.001 for depth measurements and p , 0.05
for area measurements). Statistical analysis performed on both the
groups even after excluding the two animals which had failed to
re-epithelialize (Fig 3, right two animals) also showed that Nf11/–
wounds are significantly different from Nf11/1 wounds (p , 0.05
for depth measurements). The area and depth of the regenerated
dermal scar in the Nf11/– skin wounds with muscle injury (Fig 3A,
B) was not significantly different from the Nf11/– skin wounds
without muscle injury (Fig 3A, B).
Fibroblasts in skin wounds of Nf1F/– mice show prolonged
proliferation The abnormal amount and pattern of granulation
tissue observed in Nf11/– wounds suggested that increased numbers
of fibroblasts might be present in the Nf11/– wound beds. To
begin to test this possibility, Nf11/1 and Nf11/– wound sections
were stained with a biotinylated anti-PCNA antibody, which labels
proliferating cells. Immunoreactivity was visualized as a brown
precipitate after DAB reaction. Fibroblast nuclei were identified
based on their morphology and location in the granulation bed.
As compared with Nf11/1 wounds (Fig 4A), a significantly
higher percentage of fibroblasts in the granulation bed of most
Nf11/– (n 5 9/11) wounds were labeled by anti-PCNA (Fig 4B).
Quantitation of the percentage fibroblast nuclei labeled by the
antibody revealed that wounds from Nf11/– mice had a signific-
antly higher percentage of PCNA positive cells than those from
Nf11/1 mice (p , 0.0001) (Fig 4C). Heterozygous mouse skin
wounds in which the muscle was also injured had an even higher
percentage of PCNA positive cells than Nf11/– skin wounds alone
(Fig 4C). Cell density measurements in the dermal scars of skin
wounds with muscle injury also revealed a small but significant
difference between the Nf11/1 and Nf11/– wounds (p , 0.0001)
(data not shown) consistent with accumulation of fibroblasts within
wound beds.
Nf1F/– fibroblasts in vitro show abnormal proliferation To
determine if Nf11/– fibroblasts have inherent abnormal regulation
of proliferation, in vitro growth assays were performed. Over 8 d,
in media with serum, Nf11/– and Nf1–/–embryonic fibroblasts
proliferated significantly more than Nf11/1 fibroblasts (Fig 5).
We tested if factors found in wounds could augment proliferation
of mutant fibroblasts. Macrophages are the major source of cytokines
that regulate fibroblast function in wounds (Diegelman et al, 1981).
Therefore, conditioned media of activated macrophages was added
to fibroblast cultures. Nf11/1 fibroblasts were not affected by the
addition of macrophage-conditioned media to the culture medium
(Fig 5) or by the addition of fibroblast-conditioned medium (not
shown). Nf11/– fibroblasts were also unaffected by the addition
of fibroblast-conditioned medium (not shown). In contrast, Nf11/–
fibroblasts from four of seven embryos tested showed augmentation
of proliferation in response to activated macrophage-conditioned
media (Fig 5). Fibroblasts from the remaining embryos may already
have reached maximal response in the assay. In an attempt to
identify the growth factors that contribute to the macrophage-
conditioned media activity, individual purified growth factors that
are secreted by macrophages were used in the proliferation assay.
Basic fibroblast growth factor (0.3 or 4 ng per ml), transforming
growth factor β1 and β2 (5 and 165 pg per ml), platelet-derived
growth factor BB (5 and 10 ng per ml), and midkine (5 µg per
ml) did not potentiate proliferation of Nf11/1 and Nf11/–
fibroblasts (data not shown). EGF (0.3–3 ng per ml) mimicked
the macrophage-conditioned media effect on Nf11/– fibroblasts
proliferation (Fig 5B). EGF stimulated proliferation was blocked
by the EGF receptor kinase inhibitor, tyrphostin AG1478 (Fig 5B).
AG1478 did not inhibit proliferation of fibroblasts in normal
growth conditions (Fig 5B). Addition of AG1478 to macrophage-
conditioned media did not alter its activity, suggesting that EGF is
not the predominant factor in the macrophage-conditioned medium
that potentiated Nf11/– fibroblast proliferation. Thus, mutation
in a single Nf1 allele causes abnormal fibroblast proliferation in
response to specific environmental signals including macrophage
produced growth factor(s) and EGF.
Nf1–/– fibroblast cultures have increased deposited
collagen Excess granulation tissue observed after in vivo wounding
suggested that Nf11/– fibroblasts, the chief producers of collagen
matrix in the wound bed (Mast, 1992), might produce abnormal
amounts of collagen, as well as showing increased proliferation.
Fibroblasts of all three genotypes were tested for their ability to
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Figure 1. Abnormal wound repair in Nf1F/– mouse excisional skin wounds. Gomori’s trichrome stained paraffin sections of Nf11/1 (A, C)
and Nf11/– (B, D) skin wounds were analyzed at 4 wk postwounding. Collagen appears blue–green. In (C) and (D) skin was wounded, and muscle
injured. Black arrows indicate the interface between normal skin containing hair follicles and glands and the regenerated dermal scar (A, B). In Nf11/–
mice, the fibrotic tissue of the granulation bed (series of black arrowheads in B, D) penetrates the underlying muscle fascicles (white letter M). Higher
magnification of the dermal scar from asterisked regions in (A, B) are shown in (E, F), respectively. White arrowheads (E, F) point to elongated nuclei
within the scar, suggesting that these are fibroblast nuclei. (G) Higher magnification of the double asterisked region in (B) shows the less compact fibrotic
tissue penetrating muscle. Scale bar: (A–D) 50 µm; (E–G) 10 µm.
Figure 2. Rare phenotypes in the Nf1F/– excisional skin wounds. (A–C) Gomori’s trichrome stained sections of 4 wk old excisional Nf11/–
skin wound sections were analyzed. (A) Collagen matrix and the wound bed erupted above the skin layer that failed to re-epithelialize. In (B, C), there
was a delay in normal wound healing. A thick and highly cellular granulation bed with iNflammatory cells (visible only at higher magnification),
prolonged angiogenesis (C, black arrow points to blood vessels filled with red blood cells), and lack of wound closure (A, C region between black arrowheads)
are seen. Keratinocyte hyperplasia (B, C, white arrowheads) and regeneration of the panniculus carnosus muscle layer (B, C, white arrows) are clearly evident
in (B, C). Scale bar: 100 µm.
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Figure 3. Increase in depth and area of some Nf1F/– mouse skin
scars. Wound depth (A) and area (B) from Nf11/1 and Nf11/– of 4 wk
old wounds. The depth and area of the Nf11/– skin wound group were
significantly higher than the Nf11/1 group, p , 0.0001 and p , 0.05,
t 5 –2.4, respectively, as assessed by the Student’s t-test. Each bar represents
the average of at least four measurements from random sections spanning
an individual scar’s length. ‘‘N’’ indicates wounds with muscle injury.
Depth and area measurements were performed as noted in the text. Dotted
line shows maximum height (A) and area (B) determined in 1/1 wounds.
deposit collagen in vitro. We tested the amount of collagen
deposited by Nf11/1 (13 individual embryos) and Nf11/–
(11 individual embryos) fibroblast cultures and failed to detect a
significant difference between the two genotypes (Fig 6A). Next
we investigated if complete loss of neurofibromin altered the
amount of collagen deposited. Nf1–/– fibroblast cultures (13
individual embryos) had 2–2.5-fold higher deposited collagen
(p , 0.0001) in comparison with Nf11/1 fibroblasts (Fig 6A).
Fibroblasts from three individual Nf1–/– embryos tested did not
demonstrate an increase in deposited collagen (data not shown).
The robust alteration in amount of collagen deposited by Nf1–/–
fibroblasts coupled with the increased collagen observed in Nf11/–
mice after skin wounding prompted analysis of the mechanism
underlying alteration in collagen deposition.
The increase in collagen deposited by Nf1–/– fibroblasts is
independent of Ras activity Ras activation decreases collagen
transcription in fibroblast cell lines (Hatamochi et al, 1991; Kenyon
et al, 1991; Slack et al, 1992). It therefore seemed unlikely that Ras
activation caused the increased collagen deposition observed in
Nf1–/– fibroblasts, even though Nf1 regulates Ras activation in
some cells. Consistent with the literature for fibroblast cell lines,
v-H-ras iNfected primary wild-type fibroblasts deposited extremely
low levels of collagen (Fig 6B). We also tested if Ras pathway
inhibitors could inhibit the enhanced collagen deposition in Nf1–/–
cultures. MEKK Inhibitor (MEKKI), which inhibits the Raf-
MAPK arm of the Ras pathway was used (Dudley et al, 1995) and
farnesyl protein transferase inhibitor L744832 at up to 10 µM also
Figure 4. Fibroblasts proliferate past the normal wound maturation
phase in Nf1F/– wounds. Anti-PCNA immunostaining of 4 wk old
Nf11/1 (A) and Nf11/– (B) wounds with muscle injury. PCNA-positive
(brown color) basal layer keratinocytes in the epidermis (black arrows) and
fibroblasts (white arrows) are present in the granulation bed of the regenerated
dermal scar. Hematoxylin counterstaining shows unlabeled nuclei in blue.
Scale bar: 10 µm. (C) Quantitation of anti-PCNA-labeled nuclei in wounds
with and without muscle injury. ‘‘N’’ indicates wounds with muscle injury.
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Figure 5. Increased proliferation of Nf1F/– fibroblasts to serum
factors, macrophage-conditioned media, or EGF. (A) Fibroblast
proliferation was analyzed in media with 10% FBS (solid bars) or media
with 10% FBS 1 50% macrophage-conditioned media (MCM; hatched
bars). Each set of bars represents data from fibroblasts from an individual
embryo. (B) Fibroblast proliferation stimulated by EGF, but not MCM, is
inhibited by the EGF receptor antagonist AG1478. Data show results from
a single 1/1 and 1/– embryo and are representative of three individual
experiments using cells from different embryos. Data are presented as the
mean fold increase in cell number after 8 d in duplicate cultures. Error bars
show SEM.
did not alter collagen deposition in Nf11/1 or Nf1–/– cultures
(data not shown). These data are consistent with the idea that
increases in collagen deposited by Nf1–/– fibroblasts are not
mediated through Ras.
DISCUSSION
Our in vivo studies reveal a role for Nf1 in wound healing. Skin
wound healing is a complex process consisting of inflammatory,
proliferative and maturation phases that occur in a specific sequence.
Several cell types contribute to the repair process in a coordinated
manner (reviewed in Clark, 1993; Gailit and Clark, 1994). In the
first 7 d following an excisional skin wound, a fibrin clot provides
a provisional matrix for inflammatory cell invasion and creates the
environment for the subsequent proliferative phase of multiple cell
types. In Nf11/– mice, this early phase of wound repair appears
to proceed normally. Seven to 21 d after an excisional wound,
epithelialization is completed, fibroblasts proliferate, and collagen
is synthesized in the granulation bed. In the majority of Nf11/–
wounds we analyzed, epithelialization occurred on schedule; in
only three of 40 wounds was epithelialization delayed, when
disrupted by a large dermal scar. Indeed, an increase in dermal scar
area and depth was observed in most Nf11/– wounds, indicating
an abnormal increase in the amount and persistence of granulation
tissue in the Nf11/– wound beds. Dermal connective tissue
components may differ in the skin in Nf11/1 and Nf11/– mice
and contribute to these abnormalities, but some putative changes
have not been studied. Many Nf11/– wounds also had a highly
Figure 6. Ras-independent increases in collagen deposition by
Nf1–/– embryonic fibroblasts. (A) Levels of hydroxyproline in fibroblast
cultures of various genotypes. Collagen deposition was inferred by
measurement of hydroxyproline in hydrolysates of 14 d fibroblast cultures.
Data are presented as micrograms of hydroxyproline per microgram of
detergent-soluble protein. Each bar represents the mean of triplicate cultures
in five to seven separate experiments with fibroblasts using six to 13
individual embryos. Error bars show SD and **p , 0.0001 (Student’s t-
test) between Nf11/1 and Nf1–/– fibroblast values. (B) Levels of
hydroxyproline in cultures of Nf11/1 fibroblasts as compared with Nf11/
1 fibroblasts infected with oncogenic v-H-ras (v-ras). Collagen deposition
by cells from a single Nf1–/– embryo is shown for comparison. The data
were coNfirmed in three independent experiments. Each bar represents
the average of duplicate measurements; error bars show SEM.
abnormal pattern of granulation tissue in the wound bed, in which
the granulation bed actually penetrated underlying muscle bundles.
Thus, a specific in vivo defect in granulation tissue formation has
been identified in Nf11/– mice.
Based on our in vivo and in vitro studies, we suggest that abnormal
fibroblast proliferation in wound beds is due to abnormal fibroblast
response to wound growth factors and cytokines. Nf11/– wounds
showed an abnormally high percentage of PCNA-positive
fibroblasts; fibroblast proliferation was exacerbated by muscle injury.
Potent mitogens for fibroblasts are released by injured skeletal
muscle (reviewed in Goldring and Goldring, 1991; Husmann et al,
1996). Macrophage secreted factors are the chief effectors of
fibroblast behavior in the wound bed (Diegelman et al, 1981).
Indeed, many of the same factors released by injured muscle are
also released from activated macrophages. Activated macrophages
in vitro contain a similar profile of factors and cytokines as the
wound bed (Rappole et al, 1988; Grotendorst et al, 1992). Nf11/–
fibroblasts in vitro showed increased proliferation in the presence of
macrophage-conditioned media or recombinant EGF. Because an
EGFR antagonist failed to reverse effects of macrophage-condi-
tioned media, additional effective factors must be contained in
the macrophage-conditioned media. Neurofibromin expression is
upregulated in fibroblasts after human skin wounding, and by
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exposure of human fibroblasts to PDGF and transforming growth
factor-β (Yla¨-Outinen et al, 1998). In mouse fibroblasts with Nf1
mutations, mitogenic effects subsequent to injury may be prolonged
because neurofibromin upregulation is missing.
We postulate that wound factors also contribute to collagen
deposition by Nf11/– fibroblasts. Increased numbers of prolifer-
ating fibroblasts in vivo may cause the excess in granulation tissue
in Nf11/– wound beds, or individual Nf11/– fibroblasts may
synthesize increased amounts of collagen in the wound environ-
ment. Our in vitro studies show a 2–2.5-fold increase in deposited
collagen in Nf1–/– fibroblast cultures. Nf11/– fibroblasts failed to
show abnormalities in collagen deposition in culture. Fibroblasts
from human neurofibromas have increased collagen mRNA and
secretion (Peltonen et al, 1981, 1986; Uitto et al, 1986; Sasaki et al,
1992), but the genetic status of NF1 gene in neurofibroma
fibroblasts is not known. Preliminary in vitro studies have failed to
demonstrate alterations in collagen deposition by Nf11/– fibroblasts
in the presence of macrophage-conditioned media (data not shown).
Proliferation and collagen deposition phenotypes may be regulated
differently or may require different concentrations of wound factors.
Our data suggest that fibroblasts use Ras-independent NF1
pathways for abnormal collagen deposition, because Nf11/1
fibroblasts expressing activated v-H-ras did not mimic the collagen
deposition phenotype of the Nf1–/– fibroblast in vitro. In contrast,
Schwann cells expressing the same v-H-Ras allele mimicked
Nf1-mutant Schwann cell phenotypes (Kim et al, 1995). Indeed,
primary mouse fibroblasts expressing activated Ras diminished all
tested parameters of collagen manufacture and deposition, consistent
with previous studies in fibroblast cell lines (Hatamochi et al, 1991;
Kenyon et al, 1991; Slack et al, 1992). Non-Ras functions for NF1
in fibroblasts are consistent with recent data demonstrating that
Nf1 mutant fibroblasts do not show elevated Ras-GTP (Sherman,
L. Atit, R. Cox, A. & Ratner, N, submitted). The mechanism
underlying the increased collagen deposition by Nf1–/– fibroblasts
remains unknown. Preliminary examination of key steps in collagen
biosynthesis did not reveal detectable differences in collagen mRNA
levels, secretion, processing, or gelatinase activity of fibroblasts from
various genotypes (Atit et al, unpublished observations).
Increases in wound depth and area, and abnormal pattern of
granulation tissue formation were evident in 60% of wounds from
Nf11/– mice. In vitro abnormalities in collagen deposition also
occurred in cells derived from most, but not all, embryos. Because
the environment remains constant in in vitro assays, yet responses
differed, signals present at different levels in the environment of
individual mice may not completely explain variable expressivity
and penetrance. Mice used for our studies had been backcrossed
seven to nine generations on to the C57BL/6 background, so
genetic variation is unlikely to account for the observed differences
among mice. Our in vivo studies were all performed on male mice
so sex-specific differences are also unlikely to explain differences
among animals. It is possible that neurofibromin acts in cooperation
with one or more molecules to produce the collagen-deposition
phenotype. This may occur through a non-NF1 alternate pathway
(controlled by one or more genes) that is stochastically used to
compensate for the mutation (e.g., see Horan et al, 1994). Alterna-
tively, the single active Nf1 allele may not generate enough
functional protein to rise above a threshold needed to achieve an
appropriate biologic response in all target cells (e.g., see Dunn
et al, 1997).
Fibroblasts from Nf11/– mice tested proliferated more than
fibroblasts from wild-type mice, both in vivo after wounding and
in vitro. Rosenbaum et al (1995) found no differences in proliferation
of Nf11/– fibroblasts as compared with wild-type cells, whereas
Nf1–/– fibroblasts did hyperproliferate. A difference between the
two sets of experiments is the number of backcrosses onto the
C57BL/6 background. Recessive modifier(s) in C57BL/6 may be
required together with decreased Nf1 gene dosage to evidence this
difference among animals. It is believed that modifier genes
influence expressivity of human NF1 (Easton et al, 1993).
Our examination of the wound healing process in Nf11/–
mouse skin suggests that abnormalities in skin fibroblasts could
contribute to skin abnormalities in NF1 patients. These include
hyperpigmentation (cafe´-au-lait macules, axillary and inguinal freck-
ling) (Friedman and Birch, 1997) and localized areas of skin atrophy
and hypoplasia (Norris et al, 1985). Neurofibromin is expressed in
developing and adult human skin (Malhotra and Ratner, 1994;
Hermonen et al, 1995) and is upregulated in fibroblasts after
wounding (Yla¨-Outinen et al, 1998). The healing process in human
NF1 skin has not yet been studied.
NF1 patients develop neurofibromas, benign tumors associated
with peripheral nerves that contain Schwann cells, fibroblasts, and
collagen-rich matrix. It has been suggested that wounding could
facilitate the formation of neurofibromas (Riccardi, 1992). We
have shown that injury promotes, in mice, specific features of
neurofibromas found in human patients including fibroblast hyper-
plasia and collagen accumulation. Our data support the view that
trauma and dysfunction of Nf1 mutant fibroblasts could contribute
to human neurofibroma formation.
We thank J. Florer and B. Ling for technical assistance, T. Rosenbaum and
D. Brown for initiating experiments to measure wound closure, L. James for
statistical analysis, and S. Newman for teaching us how to collect activated
macrophage medium. T. Suh, L.Sherman, and T. Bugge gave helpful comments
on the manuscript. RA is the recipient of the Univeristy of Cincinnati Dean’s
Distinguished Dissertation Award. This work was supported by NIH-R01-
NS28840 and a grant from the DOD to N.R..
REFERENCES
Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J:
Aberrant regulation of ras proteins in malignant tumour cells from type 1
neurofibromatosis patients. Nature 356:713–715, 1992
Berg RA: Determination of 3- and 4-hydroxyproline. Methods Enzymol 82:372–
398, 1982
Brannan CI, Perkins AS, Vogel KS, et al: Targeted disruption of the neurofibromatosis
type-1 gene leads to developmental abnormalities in heart and various neural
crest-derived tissues. Genes Dev 8:1019–1029, 1994
Brown RL, Breeden MP, Greenhalgh DG: PDW and TGFalpha act synergistically
to improve wound healing in genetically diabetic mouse. J Surg Res 56:562–
570, 1994
Clark RA. Mechanisms of cutaneous wound repair. In: Fitzpatrick TB, Eisen AZ,
Wolff K, Freedberg IM, Austen KF (eds). Dermatology in General Medicine. New
York: McGraw-Hill, 1993, pp 473–486
Colman SD, Williams CA, Wallace MR: Benign neurofibromas in type 1
neurofibromatosis (NF 1) show somatic deletions of the NF1 gene. Nature
Genet 11:90–92, 1995
Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the
EW receptor in signalling by G-protein-coupled receptors. Nature 379:557–
560, 1996
DeClue JE, Papageorge AG, Fletcher JA, Dieffi SR, Ratner N, Vass WC, Lowy
DR: Abnormal regulation of mammalian p2, 1 ras contributes to malignant
tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265–
273, 1992
Diegelman RF, Cohen IK, Kaplan AM: The role of macrophages in wound repair:
a review. Plast Reconstr Surg 68:107–113, 1981
Dudley DT, Pang S, Decker J, Bridges AJ, Saltiel AR: A synthetic inhibitor of the
mitogenactivated protein kinase cascade. Proc Natl Acad Sci, USA 92:7686–
7689, 1995
Dunn NR, Winner GE, Hargett LY, Schrick JJ, Fogo AB, Hogan BLM:
Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification
by mutations in G13 and AIX4. Dev Biol 188:235–247, 1997
Dvorak HF: Tumors: wounds that do not heal. N Engl J Med 315:1650–1659, 1986
Easton DF, Ponder MA, Huson SM, Ponder BAJ: An analysis of variation in
expression of neurofibromatosis type 1 (NFI): evidence for modifying genes.
Am J Hum Genet 53:305–313, 1993
Eldridge CF, Bunge MB, Bunge RP, Wood PM: Differentiation of axon-related
Schwann cells in vitro. Ascorbic acid regulates basal lamina assembly and myelin
formation. J Cell Biol 105:1023–1034, 1987
Friedman JM, Birch PH: Type 1 neurofibromatosis: a descriptive analysis of the
disorder in 1,728 patients. Am J Med Genet 70:138–143, 1997
Gailit J, Clark RA: Wound repair in the context of extracellular matrix. Curr Opin
Cell Biol 6:717–725, 1994
Goldring MB, Goldring SR: Cytokines and growth control. Crit Rev Eukaryotic Gene
Exp 1:301–326, 1991
Greenhalgh DG, Sprugel KH, Murray MJ, Ross R: PDGF and FGF stimulate
wound healing in the genetically diabetic mouse. Am J Pathol 136:1235–
1246, 1990
842 ATIT ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Griesser J, Kaufrnann D, Maier B, Mailhammer R, Kuehl P, Krone W: Post-
transcriptional regulation of neurofibromin level in cultured human melanocytes
in response to growth factors. J Invest Dermatol 108:275–280, 1997
Griffin FM, Silverstein SC: Segmental response of the macrophage plasma membrane
to a phagocytic stimulus. J Exp Med 139:323–327, 1974
Grotendorst GR: Chemoattractants and growth factors. In: Cohen IK, Diegelmann
RF, Lindbald WJ (eds). Wound Healing: Biochemical and Clinical Aspects.
Philadelphia, PA: Harcourt Brace Jovanovich, 1992, pp 237–246
Guha A, Lau N, Huvan I, Gutmann D, Provias J, Pawson T, Boss G: Ras-GTP
levels are elevated in human NFI peripheral nerve tumors. Oncogene 12:507–
513, 1996
Guo HF, The I, Hannan F, Bernards A, Zliong Y: Requirement of Drosophila NFI
for activation of adenylyl cyclase by PACAP3, 8-like neuropeptides. Science
276:795–798, 1997
Hatamochi A, Ono M, Ueki H, Namba M: Regulation of collagen gene expression
by transformed human fibroblasts: decreased type 1 and type III collagen RNA
transcription. J Invest Dermatol 96:473–477, 1991
Hermonen J, Hirvonen O, Yla¨-Outinen H, et al: Neurofibromin: expression by
normal human keratinocytes in vivo and in vitro and in epidermal malignancies.
Lab Invest 73:221–228, 1995
Horan GS, Wu K, Wolgemuth D, Behringer RR: Homeotic transformation of
cervical vertebrae in Hoxa-4 mutant mice. Proc Natl Acad Sci USA 91:12644–
12648, 1994
Husmann L, Soulet L, Gautron J, Martelly I, Barritault D: Growth factors in skeletal
muscle regeneration. Cytokine Growth Factor Rev 7:249–258, 1996
Huson SM, Clark P, Compston DAS, Harper PS: A genetic study of von
Recklinghausen neurofibromatosis in south east Wales I. Prevalence, mutation
rate, and effect of parental transmission on severity. J Med Genet 26:704–
711, 1989
Jaakkola S, Peltonen J, Riccardi V, Chu ML, Uitto J: Type I neurofibromatosis:
selective expression of extracellular matrix genes by Schwann cells, perineurial
cells, and fibroblasts in mixed cultures. J Clin Invest 84:253–261, 1989
Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour
predisposition in mice heterozygous for a targeted mutation in Nfl. Nature
Genet 7:353–361, 1994
Johnson MR, Look AT, DeClue JE, Valentine MB, Lowy DR: Inactivation of the
NF I gene in human melanoma and neuroblastoma cell lines without impaired
regulation of GTPaRas. Proc Natl Acad Sci USA 90:5539–55433, 1993
Kenyon K, Contente S, Trackman PC, Tang J, Kagan HM, Friedman RM: Lysyl
oxidase and rrg messenger RNA. Sci 253:802, 1991
Kim MR, Tamanoi F. Neurofibromatosis 1 GTPase activating protein-related
domain and its functional significance. In: Upadhyaya M, Cooper D (eds).
Neurofibromatosis Type 1: from Genotype to Phenotype. Oxford: BIOS Scientific
Publishers Ltd, 1998
Kim H, Rosenbaum T, Marchionni M, Ratner N, DeClue JE: Schwann cells from
neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell
proliferation and morphological changes. Oncogene 11:325–335, 1995
Kim HA, Ling B, Ratner N: Nf1-deficient mouse Schwann cells are angiogenic and
invasive and can be induced to hyperproliferate: reversion of some phenotypes
by an inhibitor of farnesyl protein transferase. Mol Cell Biol 17:862–872, 1997
Kobayashi M, Hashimoto N, Hoshino M, Hattori S, Iwashita S: Differential
contribution of M(r) 120kDa rasGTPase-activating protein and
neurofibromatosis type 1 gene product during the transition from growth
phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-
activity. FEBS Lett 327:177–182, 1993
Konomi H, Arima M, Tanaka H, Hayashi T, Ikeda S: Increased deposition of
types III and V collagens in neurofibroma tissue from patients with von
Recklinghausen disease. Brain Dev 11:378–382, 1989
Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nfl deficiency causes
Ras-mediated granulocyte/macrophage colony stimulating factor
hypersensitivity and chronic myeloid leukernia. Nat Genet 12:137–143, 1996
Malhotra R, Ratner N: Localization of neurofibromin to keratinocytes and
melanocytes in developing rat and human skin. J Invest Dermatol 102:812–
818, 1994
Martin P: Wound healing-aiming for perfect skin regeneration. Science 276:75–
81, 1997
Mast BA. The skin. In: Cohen IKRFD, Lindbald WJ (eds). Wound Healing Biochemical
and Clinical Aspects. Philadelphia: Harcourt Brace Jovanovich, 1992, pp 344–355
Norris JFB, Fletcher AG, Marshall PJ, Hand MJ: Neurofibromatous dermal
hyperplasia: a clinical, pharmacological, and ultrastructural study. Br J Dermatol
112:435–441, 1985
Peltonen J, Martala T, Vihersaari T, Renvall S, Pentinnen R: Collagen synthesis in
cells cultured from v. Recklinghausen’s neurofibromatosis. Acta Neuropathol
(Berl) 55:183–187, 1981
Peltonen J, Penttinen R, Laijava H, Aho HJ. Collagens in neurofibromas and
neurofibroma cell cultures. In: Rubenstein AE, Bunge RP, Housman DE
(eds). Neurofibromatosis. Annals of the New York Academy of Sciences, Vol. 486.
New York: New York Academy of Sciences, 1986, pp 260–270
Peltonen J, Jaakola S, Lebwohl M: Cellular differentiation and expression of matrix
genes in type 1 neurofibromatosis. Lab Invest 59:760–771, 1988
Rappole DA, Mark D, Banda MJ, Werb Z: Wound macrophages express TGF-
alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science
241:708–711, 1988
Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Baltimore:
Johns Hopkins University Press, 1992
Rosenbaum T, Boissy YL, Kornbrinck K, Brannan CI, Jenkins NA, Copeland NG,
Ratner N: Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.
Development 121:3583–3592, 1995
Rosenbaum T, Patrie KM, Ratner N: Neurofibromatosis type 1: genetic and cellular
mechanisms of peripheral nerve tumor formation. Neuroscientist 3:412–420, 1997
Sasaki T, Katsuhiko A, Nagai Y: Growth and collagen synthesis of cultured
neurofibroma fibroblasts. J Dermatol 19:598–601, 1992
Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D: Identification
of NF1 mutations; in both alleles of a dermal neurofibroma. Nature Genet
14:110–112, 1996
Slack JL, Parker MI, Robinson VR, Bornstein P: Regulation of collagen I gene
expression by ras. Mol Cell Biol 12:4714–4723, 1992
Sollberg S, Muona P, Lebwohl M, Peltonen J, Uitto J: Presence of type I and VI
collagen mRNAs in endothelial cells in cutaneous neurofibromas. Lab Invest
65:237–242, 1991
Uitto J, Matsuoka LY, Chu M, Pihlajaniemi T, Prockop D. Connective tissue
biochemistry of neurofibromas. In: Rubenstein AE, Bunge RP, Housman DE
(eds). Neurofibromatosis. Annals of the New York Academy Of Sciences, Vol. 486.
New York: New York Academy of Sciences, 1986, pp 271–286
Vogel KS, Brannan CI, Jerkins NA, Copeland NG, Parada LF: Loss of neurofibromin
results in neurotrophin-independent survival of embryonic sensory and
sympathetic neurons. Cell 82: 733–742., 1995
Yla¨-Outinen HY, Aaltonen V, Bjo¨rkstrand A, et al: Upregulation of tumor suppressor
protein neurofibromin in normal wound healing and in vitro evidence for
platelet derived growth factor (P13GF) and transforming growth factor-beta l
(TGF-1) elicited increase in neurofibromin mRNA steady-state levels in dermal
fibroblasts. J Invest Dermatol 110:232–237, 1998
